⌘K

Login Start Free

Home/Filings/4/0000810084-09-000001

4//SEC Filing

Makar Ralph 4

Accession 0000810084-09-000001

CIK 0000810084other

View on SEC.gov Company Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 7:01 PM ET

Size

8.4 KB

Accession

0000810084-09-000001

Insider Transaction Report

Form 4

Period: 2008-12-31

BIOJECT MEDICAL TECHNOLOGIES INCBJCT

CEO/President

Transactions

Exercise/Conversion
Restricted Stock Unit
2008-12-31−50,000→ 390,934 total
From: 2008-12-31→ BJCT Common Stock (50,000 underlying)
Exercise/Conversion
BJCT Common Stock
2008-12-31+50,000→ 295,701 total

Holdings

BJCT Common Stock
(indirect: By 401(k))
15,441

Footnotes (4)

[F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
[F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
[F3]No expiration date.
[F4]Includes Series F Preferred Stock 67,600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000 Restricted Stock Unit 166,667.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOJECT MEDICAL TECHNOLOGIES INC

CIK 0000810084

Entity typeother

Related Parties

1

filerCIK 0001414579

Filing Metadata

Form type: 4
Filed: Jan 1, 7:00 PM ET
Accepted: Jan 2, 7:01 PM ET
Size: 8.4 KB

View on SEC.gov